USE OF TOCILIZUMAB AND MESENCHYMAL STROMAL CELLS IN THE TREATMENT OF SEVERE COVID-19 - A CASE REPORT

BACKGROUND: Currently, there is no specific treatment for coronavirus disease, and some drugs and cell-based therapy have been tested as alternatives. This work aims to evaluate the effects of the combined use of humanized recombinant monoclonal antibody capable of binding the IL-6 receptor (Tociliz...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cytotherapy
Main Authors: Senegaglia, AC, Rebelatto, CLK, Franck, CL, Lima, JS, Daga, DR, Shigunov, P, Azambuja, AP, Bana, EG, Marsaro, DB, Schaidt, B, Micosky, A, Jamur, VR, Vaz, IM, Schluga, Y, Leite, LMB, Ribeiro, LL, Correa, A, Brofman, PRS
Formato: Artigo
Idioma:Inglês
Publicado em: Published by Elsevier Inc. 2021
Assuntos:
104
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8079859/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2021.02.111
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados